טוען...
RAB10: an Alzheimer’s disease resilience locus and potential drug target
Alzheimer’s disease (AD) is mainly a late-onset neurodegenerative disorder. Substantial efforts have been made to solve the complex genetic architecture of AD as a means to identify therapeutic targets. Unfortunately, to date, no disease-altering therapeutics have been developed. As therapeutics are...
שמור ב:
| הוצא לאור ב: | Clin Interv Aging |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6312396/ https://ncbi.nlm.nih.gov/pubmed/30643396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S159148 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|